Remdesivir impurities include process-related compounds, synthetic intermediates, degradation products, and nitrosamine contaminants that may arise during synthesis, formulation, or storage. As a monophosphoramidate prodrug of an adenosine analog used in antiviral therapy, impurity profiling is essential to ensure product safety, therapeutic efficacy, and regulatory compliance. All impurity compounds are structurally characterized and qualified under ICH guidelines for toxicological evaluation and analytical validation.
Pharmacopeial and non-pharmacopeial Remdesivir impurity compounds are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and stability testing. EP traceable materials are supplied with validated analytical data including purity, structural confirmation, and spectral characterization.
Structurally related compounds and synthetic analogs associated with Remdesivir are included for use in impurity identification, toxicological qualification, and regulatory submission. These materials are thoroughly characterized and conform to international standards. Related compounds are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations.
Remdesivir impurity reference standards are provided with validated analytical data including purity, NMR, and MS. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.
![((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate | NA | Remdesivir](data:image/svg+xml;nitro-empty-id=MTE5Mzo1NDQ=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNDgwIDM4NCIgd2lkdGg9IjQ4MCIgaGVpZ2h0PSIzODQiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
![(2S,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile | 1369903-46-7 | Remdesivir](data:image/svg+xml;nitro-empty-id=MTI3NTo1NDg=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNDgwIDM4NCIgd2lkdGg9IjQ4MCIgaGVpZ2h0PSIzODQiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
![(S)-2-ethylbutyl 2-((S)-(((2R,3S,4R,5S)-5-(4-aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-5-carbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) | NA | Remdesivir](data:image/svg+xml;nitro-empty-id=MTM1Nzo1NDg=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNDgwIDM4NCIgd2lkdGg9IjQ4MCIgaGVpZ2h0PSIzODQiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
![7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine | 937046-98-5 | Remdesivir](data:image/svg+xml;nitro-empty-id=MTg0NTo0NjE=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNDgwIDM4NCIgd2lkdGg9IjQ4MCIgaGVpZ2h0PSIzODQiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
![7-Iodopyrrolo[2,1-f][1,2,4]triazin-4-amine | 1770840-43-1 | Remdesivir](data:image/svg+xml;nitro-empty-id=MTkyNzo0NjE=-1;base64,PHN2ZyB2aWV3Qm94PSIwIDAgNDgwIDM4NCIgd2lkdGg9IjQ4MCIgaGVpZ2h0PSIzODQiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PC9zdmc+)
Address
Plot No. CP-135, Pimpri-Chinhwad MIDC, Pune-411019, Maharashtra, India.
© 2014-2024 SynThink Research Chemicals. All Rights Reserved.
Register to add the product to RFQ list
Already have an account? Log in here
Don’t have an account? Register here
